Case ReportProlonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma
Section snippets
Case report
A 29-year-old woman initially presented in 2001 with 6 weeks of headache and lethargy, and 4 days of left-sided facial droop and limb weakness. MRI revealed a left heterogenous 4 × 3 cm contrast-enhancing lesion near the basal ganglia and the posterior limb of the internal capsule (Fig. 1). Clinically, she responded rapidly to a course of oral dexamethasone. A frameless stereotactic-guided brain biopsy of the lesion a week later showed evidence of inflammatory demyelination (Fig. 2). For the
Discussion
Primary CNS lymphoma is a rare high-grade non-Hodgkin’s lymphoma. In immunocompetent patients, they are almost exclusively of B-cell type. The mean age at diagnosis is 60 years, with slight predominance in men. Mortality is high, and recurrence is common despite high-dose chemoradiotherapy.
Primary CNS lymphoma can be associated with preceding demyelinating pseudotumoral lesions, as briefly described in several case reports.[1], [2], [3] However, little is known about this rare occurrence. The
References (12)
- et al.
Demyelinating pseudotumoral lesion prior to a primary cerebral lymphoma
Rev Neurol
(2000) - et al.
Sentinel lesions of primary CNS lymphoma
J Neurol Neurosurg Psychiatry
(1996) - et al.
[Ghost and mimicry-tumour – Primary central nervous system lymphoma]
Nervenarzt
(2000) - et al.
Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group
N Engl J Med
(1998) Non-Hodgkin’s lymphoma in pregnancy. Three cases and review of the literature
Arch Pathol Lab Med
(1985)- et al.
[Clinical control trial of methylprednisolone and dexamethasone in treatment of intracranial tumour oedema]
Sichuan Da Xue Xue Bao Yi Xue Ban
(2003)